Adverum Biotechnologies, Inc. (ADVM) Insider Trading

Name: Adverum Biotechnologies, Inc. (ADVM) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Dec 10, 2025): Laurent Fischer (CEO, PRESIDENT AND DIRECTOR): Exercise/Conversion of 150,000 shares, $630.0K.

Get alerted when insiders trade ADVM

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta